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Abstract
Background: In the field of clinical mycobacteriology, Mycobacterium tuberculosis (MTB) can be a
difficult organism to manipulate due to the restrictive environment of a containment level 3 (CL3)
laboratory. Tests for rapid diagnostic work involving smears and molecular methods do not require
CL3 practices after the organism has been rendered non-viable. While it has been assumed that
after organism deactivation these techniques can be performed outside of a CL3, no conclusive
study has consistently confirmed that the organisms are noninfectious after the theoretical
'deactivation' steps. Previous studies have shown that initial steps (such as heating /chemical
fixation) may not consistently kill MTB organisms.
Methods: An inclusive viability study (n = 226) was undertaken to determine at which point
handling of culture extraction materials does not necessitate a CL3 environment. Four different
laboratory protocols tested for viability included: standard DNA extractions for IS6110
fingerprinting, crude DNA preparations for PCR by boiling and mechanical lysis, protein
extractions, and smear preparations. For each protocol, laboratory staff planted a proportion of
the resulting material to Bactec 12B medium that was observed for growth for 8 weeks.
Results: Of the 208 isolates initially tested, 21 samples grew within the 8-week period. Sixteen
(7.7%) of these yielded positive results for MTB that included samples of: deactivated culture
resuspensions exposed to 80°C for 20 minutes, smear preparations and protein extractions. Test
procedures were consequently modified and tested again (n = 18), resulting in 0% viability.
Conclusions: This study demonstrates that it cannot be assumed that conventional practices (i.e.
smear preparation) or extraction techniques render the organism non-viable. All methodologies,
new and existing, should be examined by individual laboratories to validate the safe removal of
material derived from MTB to the outside of a CL3 laboratory. This process is vital to establish in
house biosafety-validated practices with the aim of protecting laboratory workers conducting these
procedures.
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Background
Mycobacterium tuberculosis (MTB), the causative organism
of tuberculosis, has the distinction of repeatedly being
ranked within the top five most commonly laboratory-
acquired infections (LAIs) [1-3]. In 1976, Robert Pike pre-
pared an extensive summary based on both published
reports and surveys of 3921 LAIs that included both M.
tuberculosis and other pathogens as the infectious agent
[3]. He reported that laboratory and mortuary workers
that are exposed to tubercle material have a TB incidence
rate three times higher than that of the general population
and indicated that only 18% of infections could be traced
back to a known event. In 1987, a 25 year review at the
National Animal Disease Center (NADC) described while
only 35% of infections at the strict Biological Laboratory
at Fort Detrick, MD, had a reportable, documented cause,
the NADC could not account for 73% of LAIs occurring at
its own facility [2]. With these reported statistics, it is neg-
ligent not to consider aerosol exposure in the absence of a
known infecting episode, such as a needle prick [2]. A
more recent report from 2003 demonstrated rates from 2
to 6.6 % of TB conversion among heath care workers
(HCWs) in New York [4], in spite of current knowledge on
precautions and safety measures in place. Furthermore,
surveys suggest actual incidence of LAIs with MTB is
greater than the amount of reported cases illustrate: these
occurrences are likely underestimated due to the nature
and length of the disease progression (i.e. workers move
or retire before becoming symptomatic), and underre-
ported to the social stigma attached [1,3,5].
Due to the nature of this organism, containment level
three (CL3) laboratory operational and physical require-
ments have been recommended for manipulation of the
live organism in North America [6]. Therefore, one would
hypothesize that working in a CL3 with personal protec-
tive equipment including a respirator would be adequate
to protect the worker. However, since conversions are still
occurring, it is appropriate to consider the possibility that
the procedure one is using to deactivate and extract mate-
rial from the organism is not 100% efficient.
Currently, the application of molecular methodologies
for rapid diagnostics of MTB, such as nucleic -acid ampli-
fication based identification and subtyping schemes, in
addition to extensive genomic and proteomic research in
this area, necessitates the removal of material derived
from this organism out of a CL3 laboratory to perform the
work in a less restrictive containment level 2 (CL2) rated
area. Commonly, due to both limited CL3 space, costs
and preventative maintenance needs, high-tech equip-
ment such as liquid handling robots and sequencers are
shared and can be housed in a central "DNA core" CL2
laboratory.
To consider the biosafety impact of removing organism
material from a CL3 and manipulating it in a CL2, part of
a risk assessment undertaken included the review of cur-
rent literature on decontamination verification and viabil-
ity testing of M. tuberculosis. The existing literature is
limited in regards to viability testing of material derived
from MTB with respect to safe manipulation outside of a
Biological Safety Cabinet (BSC). To date, no conclusive
study has confirmed that this organism is noninfectious
after theoretical 'deactivation' steps. A few reports con-
cerning survival after different heating kill treatments for
DNA extractions [7-9], heat fixing of smears [10,11] and
chemical fixation [12] were found.
Since, by definition, a risk assessment is based on, but not
limited to, the properties of the agent used, personal risk
factors, manipulation techniques, and the training and
experience of staff, it is necessary to develop a method
encompassing these factors to validate the safe removal of
material derived from MTB from a CL3 laboratory for use
in other laboratory areas. This approach was applied to all
our methodologies and took into consideration variables
such as interpersonal technique, culture load, temperature
fluctuations and statistical significance.
Methods
The current viability study consisted of the evaluation of a
total of 226 material extracts, consisting of 208 initial
extracts and 18 extracts tested after revision of faulty pro-
tocols (figure 1). For each test performed, laboratory staff
members sub-cultured a proportion (100 uL) of the
resulting material to Bactec 12B radiometric medium
(Becton Dickinson, Oakville, ON) that was kept for eight
weeks to observe for growth. The vials were incubated at
37°C and the growth index (GI) was read weekly on
BACTEC 460 machines. All vials with positive GIs were
sub-cultured to tryptic soy agar (TSA) with 5% sheep
blood, Middlebrook 7H10 agar and stained with the
Kinyoun method for the presence of acid-fast bacilli
(AFB). Those positive for AFB were examined for the pres-
ence of MTB using a DNA probe specific for M. tuberculosis
complex, Accuprobe (GenProbe, San Diego, CA). Meth-
ods that resulted in viable MTB were revised and retested.
All work completed was performed in a CL3 environment,
using Class II Type B2 biosafety cabinets (BSCs), and per-
sonal protective equipment (PPE) including N100 partic-
ulate respirators, double gloves, and protective gowns.
The following describe the protocols used in our labora-
tory at the start of this study.
DNA extraction for IS6110 fingerprinting
This was performed according to the standard protocol
[13]. A total of 125 Bactec 12Bs were inoculated with 0.1
mL of lysate materials. For initial heat deactivation steps,
1.5 mL screw-cap tubes were placed in a water-bathBMC Infectious Diseases 2005, 5:4 http://www.biomedcentral.com/1471-2334/5/4
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maintained at 80°C. The tubes were not submerged.
Three technicians normally performing the procedure
inoculated 12B media at different steps of the lysate pro-
tocol. Twenty-four samples were processed up to the point
of lysozyme and proteinase K addition, prior to CTAB
addition, and tested for viability. In 30 other samples the
protocol was continued with the addition of choro-
form:isoamyl alcohol and subsequently centrifuged into
organic and aqueous phases. For 10 samples, the organic
(bottom) layer that is normally discarded was inoculated
into 12B vials and the remaining 20 samples had their
aqueous (top) layer planted. Sixty-one samples were proc-
essed to completion and inoculated into 12B vials.
Finally, 10 extracts from frozen storage (-20°C) were ret-
roactively tested by inoculation to 12B media.
Crude lysate preparation
A total of 45 lysates used for PCR testing were tested for
viability. Thirty-six lysates were prepared from actively
growing cultures by three technicians that normally per-
form the testing procedure. Briefly, a loopful of culture is
placed in a pyrex glass bottle containing 1 mL distilled
water and glass beads and vortexed in a BSC. Generally
this suspension has a turbidity of > 1 McFarland. This sus-
pension is transferred to a screw-capped vial and is placed
in a boiling water bath for 10 minutes followed by trans-
fer into a tube containing 0.5 mm silica beads and
mechanically lysed for 2 minutes with a Mini-8-Bead-
beater (BioSpec Products, Bartlesville, OK). The resulting
lysate is spun down for removal of debris and the super-
natant transferred to a new tube to be used for PCR.
Overall study flow chart with results after eight weeks incubation of material at 37°C Figure 1
Overall study flow chart with results after eight weeks incubation of material at 37°C
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Lysates were processed in duplicate and the position in
water bath was noted (i.e. periphery or centre). A
proportion of lysates (100 uL) were planted pre and post
bead-beating. An additional nine previously frozen lysates
stored at -20°C were also inoculated into 12B media (n =
45 lysates).
Smear preparation
Slides were prepared in duplicate according to our stand-
ard protocol: a loopful of organism is suspended in water
with beads, vortexed and one drop added to a glass slide
containing one drop of 0.5% phenol serum (made in-
house). The slides were allowed to dry and were placed on
a 95°C slide-warmer (Lab-Line Instruments, Melrose
Park, IL) for 15, 30, 45 minutes, 1, 1.5 and 2 hours (n =
12 slides). The heat fixed slide material was emulsified
using a sterile swab and sterile distilled water. The suspen-
sion was transferred to a pyrex glass bottle containing 1
mL sterile water with beads, vortexed and 100 µl was inoc-
ulated into a 12B media vial.
Protein extraction
Twenty-six extractions of M. tuberculosis organism were
processed as follows. A volume of 25 mL of Middlebrook
7H9 broth was inoculated and incubated at 37°C for 20
days. The culture was centrifuged at 1900 × g for 15 min-
utes at room temperature and the pellet was resuspended
with 2 ml of ice-cold phosphate buffer solution (PBS) pH
6.8 supplemented with 1% Tween-80. The sample was
centrifuged as before at 4°C and the pellet washed twice
in ice-cold 1% Tween-80 in PBS. Silicon beads (0.5 mm)
and 500µl lysis buffer (2% CHAPS, 2% Triton X-100, 9.5
M urea and 1% DTT/TBP in water) were added to the pel-
let. The sample was mechanically lysed for 30 seconds and
cooled on ice for 30 seconds, repeated eight times. The
sample was then filter sterilized with a PES membrane,
0.22 µm Millipore filter unit (Millipore, Etobicoke, ON)
into a 2 ml microcentrifuge tube on ice and stored at -
80°C.
Results
In total, 226 samples were tested for viability. As described
below, 21 samples grew within the 8-week period, with 16
of those samples from three separate procedures yielding
positive growth for M. tuberculosis (figure 1).
Of the 125 RFLP lysates tested, 2 of 24 sample materials
that were tested for viability before addition of CTAB
remained viable for M. tuberculosis. Following the com-
plete extraction protocol as described [13], cultured sam-
ples yielded 0% viability for M. tuberculosis. Four of ten
12B media vials planted with lysates from frozen storage
did show growth, and upon further investigation were
determined to be contaminants (Table 1). All other vials
had negative GI readings after 8 weeks of incubation.
Forty-five vials of TB PCR lysates were tested for viability.
With the exception of one sample that was positive for
growth and was later shown to be a contaminant (Table
1), all were negative for viable M. tuberculosis.
Table 1: Results of positive Bactec 12B vials (n = 21).
Description of 
material
Growth on TSA + 
5% SBA @ 48 hrs
Growth on 
Middlebrook 7H11
Kinyoun Stain direct from 
positive 12B
Probe Conclusion
RFLP lysate – before 
CTAB addition (2 
vials)
-+ , MTB morphology AFB+ (4+), serpentine cording ND Viable MTB1
RFLP lysate from 
frozen storage #1
-+ , KS of growth AFB - 4 AFB/slide, morph not 
consistent with TB
MTB- contaminant present – 
ubiquitous 
mycobacteria
RFLP lysate from 
frozen storage #2
-+ , KS of growth AFB - 15 AFB/slide, morph not 
consistent with TB
MTB- contamination present 
– ubiquitous 
mycobacteria
RFLP lysate from 
frozen storage #3 & 
#4
-+ , KS of growth AFB - No AFB contamination present
Boiled lysate -+ , Smooth colonies not 
consistent with MTB
AFB+ 5–10/field, clumping, no 
obvious serpentine cording
MTB- ubiquitous 
mycobacteria
Smear, 1 h at 95°C & 
Smear, 2 h at 95°C2
-+ , MTB morphology AFB+ (4+), serpentine cording MTB+ Viable MTB
Protein extracts (2) - +, MTB morphology AFB+ (4+), serpentine cording MTB+ Viable MTB
1 Accuprobe was not performed on these isolates, as MTB was expected due to morphology observed in addition to data from prior studies [7].
2 All 12Bs from smears (n = 12) were positive, only 2 were chosen as representative for further testing Definitions: KS = Kinyoun stain, AFB = acid-
fast bacilli, MTB = M. tuberculosisBMC Infectious Diseases 2005, 5:4 http://www.biomedcentral.com/1471-2334/5/4
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All vials containing suspensions from slide material that
had been incubated for less than 1 hour on the slide-
warmer exhibited identical growth rates, with a positive
12B vial in two weeks. Vials containing suspensions from
slides that were incubated greater than 1 hour exhibited
identical growth rates and had a positive 12B vials in 3–4
weeks. All 12 12B vials were positive for growth at 4 weeks
incubation. Two representative vials were chosen for fur-
ther analysis (1 hour and 2 hour slide incubations). These
12B culture vials were confirmed positive for M. tuberculo-
sis complex using Accuprobe, in addition to displaying
colony morphology consistent with TB on subculture to
Middlebrook 7H10 agar and being AFB positive with the
Kinyoun stain.
Two of 25 vials tested for viability from protein extrac-
tions became positive. Confirmation of viable MTB in
these test vials was confirmed as described above. Based
on these results, the methods for slide fixation and pro-
tein extraction were modified. Slides were fixed prior to
staining using 5% phenol in ethanol according to
Chedore et al. [10], and protein extractions samples were
centrifuged at 4°C after lysis steps to rid the supernatant
of cell debris before filter sterilization. These modified
tests were planted again for growth of MTB, resulting in
0% organism viability for every test performed by each
laboratory worker (Table 1). To date, ongoing viability
testing of these tests have not shown any growth (data not
shown).
Discussion
There are few publications that review the efficacy of
methodologies that render material extracts from a M.
tuberculosis culture non-viable [7-10]. One such study by
Bemer-Melchior et al. was prompted by a case of pulmo-
nary tuberculosis acquired by a laboratory technician per-
forming the standard method for IS6110-RFLP in a CL3
mycobacteriology [7]. In this study, placing the organisms
in 80°C for 20 minutes gave breakthrough growth, which
was also observed in our laboratory. Conflicting informa-
tion exists which claims 100% loss of viability using this
method, however, this report outlines potential reasons
for the difference, such as the complete submersion of
sample tubes, or volume and density of the suspension
[9].
Bemer-Melchior et al. also found that submerging the cul-
ture at 100°C for 5 minutes rendered the sample com-
pletely non-infectious; data that was supported by work
previously done in 1994 by Zwadyk et al. [8]. Although
these studies were the first of its kind in verifying the safety
of laboratory protocols and addressed issues regarding
temperature, timing, cell density and sample volume in
deactivating MTB cultures, they clearly demonstrated that
certain methods of heating may not be efficient in com-
plete sterilization of a MTB culture. With the unique cell
wall characteristics and ability of MTB to clump (or cord),
variables to be considered include cell mass density,
actual temperature reached and actual time exposed to the
heat source. Zwadyk et al. showed that using a 95°C heat
block failed to completely inactivate the culture, and in
fact, using an internal temperature probe demonstrated
that the tube did not reach the intended temperature even
after 20 minutes [8]. Another study issued a caution in
removing MTB fixed with 0.5 – 1% glutaraldehyde from a
CL3 as the process used to sterilize the culture failed [12].
Again, both the efficacy of rendering MTB material non-
viable as well as the effect of the clumping or cording fac-
tors not being known was questioned. Therefore, testing
all deactivation methods was recommended for all prepa-
rations in this laboratory [12]. In preparing a risk assess-
ment for our CL3, it became evident that this was a
necessary course of action to reduce the risk of LAIs for
both CL3 and CL2 mycobacteriology staff as well as other
non-mycobacteriology laboratory staff in the shared CL2
environment.
Genomic extractions, the most commonly performed test
in our laboratory, are conducted using the standardized
method outlined in 1997 by Van Embden et al for the pur-
pose of RFLP typing [13]. Prior viability testing of this
method in our lab showed that lysates contained viable
MTB with the initial deactivation steps of this protocol,
heating for 20 minutes at 80°C with addition of lysozyme
and proteinase K, and thus could not be removed from
containment until DNA extraction with CTAB. It is pre-
sumable that the small rate of viability observed (2 of 24),
which is similar to what was seen by Bemer-Melchior et
al., resulted from incompletely submerging sample tubes
or cell density within the tube [9]. However, phenol-chlo-
roform extraction such as the CTAB method and heating
of specimens should be lethal to mycobacteria since phe-
nolic-based disinfectants have been shown to be tubercu-
locidal [14], and to date our results reflect this fact.
To both preserve the integrity of genomic DNA for the use
of fingerprinting and allow the sample to be further proc-
essed safely outside a CL3 laboratory, it is recommended
to complete DNA extractions with CTAB as per the stand-
ard protocol to confirm the complete inactivation of M.
tuberculosis. Further sampling of the DNA extractions per-
formed in our laboratory (10% of each lysate batch) is
ongoing for quality assurance purposes, i.e. to confirm
integrity of reagents as well as to monitor staff perform-
ance and adherence to protocol. In addition, continuous
sampling attaches statistical significance to the claim that
this method ensures that the extracted material is 100%
non-viable and guarantees staff safety.BMC Infectious Diseases 2005, 5:4 http://www.biomedcentral.com/1471-2334/5/4
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For procedures that do not require intact, high quality
DNA such as PCR testing, our laboratory depends on the
much more expedient lysate method of boiling culture at
100°C for 10 minutes, followed by mechanical lysis for 2
minutes to release DNA. Although crude, this procedure is
adequate for our PCR testing needs, has been shown to
completely destroy live organism in our laboratory, and is
consistent with other studies [7,8]. The study by Zwadyk
et al. concluded that inactivating mycobacteria by heat lys-
ing at a temperature of 100°C for 30 minutes did not
inhibit its ability to be amplified by PCR or strand dis-
placement amplification [8]. Furthermore, this study has
shown that inoculating the boiled lysate alone without
mechanical lysis was adequate in rendering the sample
non-viable.
The viability testing of the two methods outlined above
for DNA extractions were performed by various techni-
cians who routinely follow these procedures, lending
interpersonal variability to the study. It was demonstrated
that the small nuances to procedure, such as the varying
density of culture used, did not affect the method
employed to deactivate the organism.
The last routine test assessed for organism viability was
the slide preparation. While phenolics are known to be
tuberculocidal, the use of phenol serum alone or in con-
junction with heat in slide preparation is not sufficient for
killing of the live organism. Flaming of the slide was not
an option due to facility requirements that prohibit open
flames inside a BSC, despite this, flaming of smear mate-
rial was found in prior studies to unsuccessfully inactivate
smear material [10]. The primary method for slide fixa-
tion was a 2-hour incubation at 95°C on the slide-
warmer, which was assumed adequate for staining pur-
poses. Slides were then transported to an area where res-
pirator usage was not mandatory. It was discovered that
every slide preparation was positive for viable TB. As a
consequence of the viability testing and subsequent risk
analysis, the protocol was altered to include chemical fix-
ation with a 5% fixative of phenol:ethanol [10]. This
allows lab staff to safely remove slides from a CL3 area
and examine slides under a microscope without interfer-
ence by the need to wear a bulky respirator.
Examining laboratory protocols for staff and building
safety should be an integral part of any CL3 laboratory
program. Implementation of a policy to test all proce-
dures used routinely for viability in addition to new meth-
odologies is highly recommended. As an example,
applying this policy to a new procedure being utilized in
the research arm of our laboratory proved valid: a protein
extraction method being developed initially showed that
of 2/26 tested samples yielded viable MTB. The researcher
concluded that it was due to a clogging of the filter from
large particles in the lysed culture used to isolate the pro-
teins and revised the protocol to centrifuge the mixture
after final lysis steps to remove cellular debris before filtra-
tion. This has proven successful so far, and continuous
sampling of extracts is ongoing before removing the mate-
rial from the CL3. To date, all have been negative.
Conclusions
It is imperative to evaluate and record the actual rate of
viability of DNA lysates from deactivated MTB cultures in
individual laboratory settings [12]. This includes all mate-
rial removed from the CL3 area. This process is vital to
establish biosafety validated procedures and practices to
protect laboratory workers conducting these procedures
[2].
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